Detalhe da pesquisa
1.
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
Cell
; 184(7): 1821-1835.e16, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33667349
2.
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.
Cell
; 184(7): 1804-1820.e16, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691139
3.
Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination.
J Immunol
; 212(1): 24-34, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37975667
4.
Assessment of Humoral Immune Responses to Repeated Influenza Vaccination in a Multiyear Cohort: A 5-Year Follow-up.
J Infect Dis
; 229(2): 322-326, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37624957
5.
The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines.
J Immunol
; 209(1): 5-15, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697384
6.
Dual oxidase 1 promotes antiviral innate immunity.
Proc Natl Acad Sci U S A
; 118(26)2021 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168077
7.
Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
J Virol
; 96(7): e0165221, 2022 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35289635
8.
Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies.
J Virol
; 96(16): e0089622, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35916534
9.
SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.
J Virol
; 96(5): e0179121, 2022 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936487
10.
Evaluation of determinants of the serological response to the quadrivalent split-inactivated influenza vaccine.
Mol Syst Biol
; 18(5): e10724, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35514207
11.
Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability.
Mol Pharm
; 20(9): 4687-4697, 2023 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603310
12.
New Proteomic Signatures to Distinguish Between Zika and Dengue Infections.
Mol Cell Proteomics
; 20: 100052, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33582300
13.
Glycomic analysis of host response reveals high mannose as a key mediator of influenza severity.
Proc Natl Acad Sci U S A
; 117(43): 26926-26935, 2020 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046650
14.
Prevaccination Glycan Markers of Response to an Influenza Vaccine Implicate the Complement Pathway.
J Proteome Res
; 21(8): 1974-1985, 2022 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35757850
15.
Template-Assisted De Novo Sequencing of SARS-CoV-2 and Influenza Monoclonal Antibodies by Mass Spectrometry.
J Proteome Res
; 21(7): 1616-1627, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35653804
16.
Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.
J Virol
; 95(4)2021 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208445
17.
Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
J Virol
; 95(17): e0075921, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34160258
18.
A Competitive Hemagglutination Inhibition Assay for Dissecting Functional Antibody Activity against Influenza Virus.
J Virol
; 95(23): e0237920, 2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34523961
19.
Emotional Distress, Targeted Rejection, and Antibody Production After Influenza Vaccination in Adolescence.
Psychosom Med
; 84(4): 429-436, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35100185
20.
A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin.
J Immunol
; 204(2): 375-385, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811019